Regeneron Pharmaceuticals Inc (REGN) Insider Trading
- $2,302,592,942.58
- $1,647,377,952.91
- Aug. 28, 2024
- Sanofi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 28, 2024 | CFO | 5,680 | $1,205.33 | Sell | $6,846,274.40 | |
| Aug. 7, 2024 | VP | 487 | $1,070.00 | Sell | $521,090.00 | |
| July 11, 2024 | EVP | 1,866 | $1,088.95 | Sell | $2,031,980.70 | |
| July 1, 2024 | EVP | 1,137 | $1,047.11 | Sell | $1,190,564.07 | |
| July 1, 2024 | Director | 100 | $1,059.24 | Sell | $105,924.00 | |
| June 24, 2024 | Director | 756 | $1,062.00 | Sell | $802,872.00 | |
| June 14, 2024 | Director | 1,535 | $1,040.00 | Sell | $1,596,400.00 | |
| June 11, 2024 | CEO | 9,064 | $1,015.43 | Sell | $9,203,857.52 | |
| June 6, 2024 | CEO | 787 | $1,015.02 | Sell | $798,820.74 | |
| June 5, 2024 | Director | 827 | $1,011.00 | Sell | $836,097.00 | |
| May 28, 2024 | Director | 1,172 | $974.86 | Sell | $1,142,535.92 | |
| May 17, 2024 | CEO | 22,830 | $979.23 | Sell | $22,355,820.90 | |
| May 14, 2024 | CEO | 25,000 | $979.25 | Sell | $24,481,250.00 | |
| March 14, 2024 | EVP | 5,783 | $956.47 | Sell | $5,531,266.01 | |
| March 1, 2024 | EVP | 358 | $967.50 | Sell | $346,365.00 | |
| March 1, 2024 | Director | 100 | $982.05 | Sell | $98,205.00 | |
| Feb. 26, 2024 | Director | 854 | $979.25 | Sell | $836,279.50 | |
| Feb. 22, 2024 | EVP | 1,000 | $967.65 | Sell | $967,650.00 | |
| Feb. 7, 2024 | EVP | 1,000 | $950.00 | Sell | $950,000.00 | |
| Feb. 5, 2024 | EVP | 1,000 | $934.71 | Sell | $934,710.00 | |
| Feb. 1, 2024 | Director | 100 | $954.22 | Sell | $95,422.00 | |
| Jan. 30, 2024 | Director | 827 | $959.00 | Sell | $793,093.00 | |
| Jan. 23, 2024 | Director | 2,707 | $950.00 | Sell | $2,571,650.00 | |
| Dec. 27, 2023 | SVP | 2,448 | $856.71 | Sell | $2,097,226.08 | |
| Dec. 27, 2023 | Director | 2,049 | $898.00 | Sell | $1,840,002.00 | |
| Dec. 21, 2023 | SVP | 1,680 | $844.01 | Sell | $1,417,936.80 | |
| Dec. 1, 2023 | Director | 100 | $817.30 | Sell | $81,730.00 | |
| Nov. 7, 2023 | Director | 100 | $827.90 | Sell | $82,790.00 | |
| Nov. 1, 2023 | EVP | 1,000 | $783.91 | Sell | $783,910.00 | |
| Oct. 13, 2023 | Director | 1,000 | $850.00 | Sell | $850,000.00 | |
| Oct. 2, 2023 | EVP | 1,038 | $827.00 | Sell | $858,426.00 | |
| Aug. 24, 2023 | EVP | 6,197 | $841.71 | Sell | $5,216,076.87 | |
| Aug. 23, 2023 | CFO | 223 | $844.00 | Sell | $188,212.00 | |
| Aug. 23, 2023 | Director | 12,280 | $839.97 | Sell | $10,314,831.60 | |
| Aug. 22, 2023 | EVP | 11,665 | $840.98 | Sell | $9,810,031.70 | |
| Aug. 21, 2023 | Director | 853 | $829.00 | Sell | $707,137.00 | |
| Aug. 10, 2023 | Director | 853 | $789.00 | Sell | $673,017.00 | |
| Aug. 1, 2023 | Director | 100 | $736.59 | Sell | $73,659.00 | |
| July 3, 2023 | EVP | 250 | $710.09 | Sell | $177,522.50 | |
| July 3, 2023 | Director | 100 | $716.88 | Sell | $71,688.00 | |
| June 1, 2023 | Director | 100 | $735.42 | Sell | $73,542.00 | |
| June 1, 2023 | EVP | 250 | $736.00 | Sell | $184,000.00 | |
| April 21, 2023 | Director | 3,070 | $798.42 | Sell | $2,451,149.40 | |
| April 3, 2023 | Director | 100 | $819.31 | Sell | $81,931.00 | |
| April 3, 2023 | EVP | 1,100 | $818.80 | Sell | $900,680.00 | |
| March 27, 2023 | CFO | 183 | $821.70 | Sell | $150,371.10 | |
| March 24, 2023 | Director | 1,240 | $818.00 | Sell | $1,014,320.00 | |
| March 23, 2023 | Insider | 3,656 | $804.26 | Sell | $2,940,374.56 | |
| March 23, 2023 | SVP | 2,192 | $806.47 | Sell | $1,767,782.24 | |
| March 1, 2023 | EVP | 1,100 | $759.89 | Sell | $835,879.00 |
Insiders are both buying and selling Regeneron Pharmaceuticals Inc stock.
The insider traders at Regeneron Pharmaceuticals Inc are: Sanofi, Joseph L Goldstein, Robert E Landry, Arthur F Ryan, Marion Mccourt, Michael S Brown, P Roy Vagelos, George L Sing, Neil Stahl, Bonnie L Bassler, Leonard S Schleifer, Christopher R Fenimore, Joseph J Larosa, Plew Daniel P Van, George Yancopoulos, Michael S Aberman, Marc Tessier-Lavigne, Charles A Baker, Robert J Terifay, Andrew J Murphy, Joseph Goldstein, Peter Powchik, Douglas S Mccorkle, Alfred Gilman, Murray Goldberg, Plew Daniel P. Van, Plew Daniel Van, Robert E. Landry, Douglas Mccorkle, Huda Y Zoghbi, Christine A Poon, Michael Brown, Michael S. Brown, Murray A Goldberg, N Anthony Coles, William Roberts, Arthur F. Ryan, Bonnie L. Bassler, Charles A. Baker, Charles Baker, Douglas S. Mccorkle, George Sing, Jason Pitofsky, Joseph L. Goldstein, Leonard Schleifer, Michael Aberman, Robert Alexander Ingram, Robert Terifay, and Alfred G Gilman
The most active insider trader at Regeneron Pharmaceuticals Inc is Sanofi with 39 trades.
Leonard S Schleifer has sold the most Regeneron Pharmaceuticals Inc stock with a total value of $335,429,753.65.
Sanofi has bought the most Regeneron Pharmaceuticals Inc stock with a total value of $2,337,432,816.66.
The most recent insider trade for Regeneron Pharmaceuticals Inc was on Aug. 28, 2024.
The single biggest insider buy for Regeneron Pharmaceuticals Inc was from Sanofi with a total value of $125,731,578.12 on March 11, 2014.
The single biggest insider sell for Regeneron Pharmaceuticals Inc was from Leonard S Schleifer with a total value of $130,006,000.00 on Aug. 18, 2021.